Novartis/Aventis Merger Would Pair Rx-to-OTC Experience With Allegra
This article was originally published in The Tan Sheet
Executive Summary
Novartis would bring a proven track record in Rx-to-OTC switches to a combination with the French pharmaceutical firm Aventis